A randomized controlled trial of early intervention with intraarticular corticosteroids followed by sulfasalazine versus conservative treatment in early oligoarthritis

Arthritis Care and Research

Volumn 57, Issue 1, 2007, Pages 154-160

  Marzo Ortega, Helena ^a   Green, Michael J ^a   Keenan, Anne Maree ^a   Wakefield, Richard J ^a   Proudman, Susanna ^b   Emery, Paul ^a  

^a CHAPEL ALLERTON HOSPITAL   (United Kingdom)

^b ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

Corticosteroids; Early arthritis; Oligoarthritis; Outcome; Prognosis

Indexed keywords

CORTICOSTEROID; DISEASE MODIFYING ANTIRHEUMATIC DRUG; METHYLPREDNISOLONE; NONSTEROID ANTIINFLAMMATORY AGENT; SALAZOSULFAPYRIDINE;

ADD ON THERAPY; ADULT; ARTHRITIS; ARTICLE; CLINICAL TRIAL; CONSERVATIVE TREATMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE ACTIVITY; DISEASE DURATION; EMPLOYMENT; FEMALE; FUNCTIONAL ASSESSMENT; HEALTH ASSESSMENT QUESTIONNAIRE; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOARTHRITIS; PAIN ASSESSMENT; POLYARTHRITIS; PROGNOSIS; PSORIATIC ARTHRITIS; QUESTIONNAIRE; REMISSION; RHEUMATOID ARTHRITIS; SYNOVITIS; TREATMENT OUTCOME; VISUAL ANALOG SCALE; WORK DISABILITY;

ADRENAL CORTEX HORMONES; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIRHEUMATIC AGENTS; ARTHRALGIA; ARTHRITIS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INJECTIONS, INTRA-ARTICULAR; MALE; MIDDLE AGED; PAIN MEASUREMENT; SULFASALAZINE; SYNOVITIS; TREATMENT OUTCOME;

EID: 33846989309     PISSN: 21514658     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.22467     Document Type: Article

References (11)

1. Kvien TK, Glennas A, Melby K, Granfors K, Andrup O, Karstensen B, et al. Reactive arthritis: incidence, triggering agents and clinical presentation. J Rheumatol 1994;21:115-22.
2. Egsmose C, Hansen TM, Andersen LS, Beier JM, Christensen L, Ejstrup L, et al. Limited effect of sulphasalazine treatment in reactive arthritis: a randomised double blind placebo controlled trial. Ann Rheum Dis 1997;56:32-6.
3. Fan PT, Yu DT. Spondyloarthropathies. In: Kelly WN, Harris ED, Ruddy S, Sledge CB, editors. Textbook of rheumatology. Philadelphia: WB Saunders; 1993.
4. Quinn MA, Green MJ, Marzo-Ortega H, Proudman S, Karim Z, Wakefield RJ, et al. Prognostic factors in a large cohort of patients with early un differentiated inflammatory arthritis after application of a structured management protocol. Arthritis Rheum 2003;48:3039-45.
5. Parker JD, Capell HA. An acute arthritis clinic: one year's experience. Br J Rheumatol 1986;25:293-5.
6. Green M, Marzo-Ortega H, Wakefield RJ, Astin P, Proudman S, Conaghan PG, et al. Predictors of outcome in patients with oligoarthritis: results of a protocol of intraarticular corticosteroids to all clinically active joints. Arthritis Rheum 2001;44:1177-83.
7. Glennas A, Kvien TK, Melby K, Refvern OK, Andrup O, Karstensen B, et al. Acute sarcoid arthritis: occurrence, seasonal onset, clinical features and outcome. Br J Rheumatol 1995;34:45-50.
8. Kuipers JG, Scharmann K, Wollenhaupt J, Nettelnbreker E, Hopf S, Zeidler H. Sensitivities of PCR, MicroTrak, ChlamydiaEIA, IDEIA, and PACE 2 for purified Chlamydia trachomatis elementary bodies in urine, peripheral blood, peripheral blood leukocytes, and synovial fluid. J Clin Microbiol 1995;33:3186-90.
9. Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum 1980;23:137-45.
10. Wakefield RJ, Green MJ, Marzo-Ortega H, Conaghan PG, Gibbon WW, McGonagle D, et al. Should oligoarthritis be reclassified? Ultrasound reveals a high prevalence of subclinical disease. Ann Rheum Dis 2004;63:382-5.
11. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.